Hedge Fund Wagers Million on Biotech After FDA Milestone
A major hedge fund just placed a multi-million bet on a biotech company after FDA approval. This article breaks down ...
Visa Credit Cards With Best Travel Rewards Programs
Find Visa credit cards that feature the best travel rewards programs, enhancing your journey with every purchase.
17,235 articlesBank of America Extends Community Homeownership Commitment
Bank of America will keep funding housing affordability efforts, surpassing its initial goal and making the Community...
Betting Stocks Soccer's Event: Two Plays Beyond the Obvious
Soccer's biggest tournament is moving to North America in 2026 with an expanded field and a booming betting market. T...
Spacex Stock Surged After IPO: What Wall Street Sees Next
SpaceX exploded onto the public markets, and the initial gains grabbed headlines. Two veteran analysts share what the...
Five Hidden Stocks Betting on AI’s Next Phase Ahead
With AMD’s rally making headlines, a slate of overlooked names could ride the AI and defense cycle higher. Here are f...
Reasons SpaceX Stock Could Fall 30% by 2028: Three Risks Investors Should Watch
SpaceX has dazzled investors, but big bets come with big risks. This article explains three reasons reasons spacex st...
Hultquist HECM Reforms: Proprietary Loans and Talent
HUD opens a formal review of HECM reforms as proprietary reverse mortgage options expand. Industry leaders weigh in o...
Canaccord Slashes AeroVironment Target Yet Keeps Buy Rating
Canaccord Genuity lowers AeroVironment's target to $330 but preserves a Buy rating, underscoring long-term optimism a...
Dead Reckoning: Nobody Does the True Cost of Housing
A missing, nationwide accounting of subsidies per affordable unit clouds the price tag of affordable housing. This re...
Why Intuitive Machines Stock Popped Today: Key Catalysts and What It Means
Intuitive Machines stock popped today as analysts weigh backlog, milestones, and funding signals. This article breaks...
Why Axsome Therapeutics Stock Reaches Another High
Axsome Therapeutics stock keeps climbing, hitting another high as regulatory news and a solid quarterly update bolste...
UBS Upgrades Jazz Pharmaceuticals to Buy, Sets $307 Target
UBS has lifted Jazz Pharmaceuticals to Buy with a $307 price target, arguing that improving fundamentals and a stren...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status